{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:05:58Z","timestamp":1790712358129,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1477-3155-12-23","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T14:36:27Z","timestamp":1403188587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Chitosan Hydrogel as siRNA vector for prolonged gene silencing"],"prefix":"10.1186","volume":"12","author":[{"given":"Zhiwei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qintao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"288_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1600-0757.2010.00355.x","volume":"54","author":"M Koide","year":"2010","unstructured":"Koide M, Kinugawa S, Takahashi N, Udagawa N: Osteoclastic bone resorption induced by innate immune responses. Periodontol 2000. 2010, 54: 235-246.","journal-title":"Periodontol 2000"},{"key":"288_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2165\/11318190-000000000-00000","volume":"23","author":"M Lopez-Fraga","year":"2009","unstructured":"Lopez-Fraga M, Martinez T, Jimenez A: RNA interference technologies and therapeutics: from basic research to products. BioDrugs. 2009, 23: 305-332.","journal-title":"BioDrugs"},{"key":"288_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2011.04.006","volume":"131","author":"E Sotillo","year":"2011","unstructured":"Sotillo E, Thomas-Tikhonenko A: Shielding the messenger (RNA): microRNA-based anticancer therapies. Pharmacol Ther. 2011, 131: 18-32.","journal-title":"Pharmacol Ther"},{"key":"288_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2007.01.003","volume":"114","author":"P Gonzalez-Alegre","year":"2007","unstructured":"Gonzalez-Alegre P: Therapeutic RNA interference for neurodegenerative diseases: from promise to progress. Pharmacol Ther. 2007, 114: 34-55.","journal-title":"Pharmacol Ther"},{"key":"288_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2007.12.007","volume":"48","author":"J Lupberger","year":"2008","unstructured":"Lupberger J, Brino L, Baumert TF: RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle. J Hepatol. 2008, 48: 523-525.","journal-title":"J Hepatol"},{"key":"288_CR6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.biomaterials.2010.09.062","volume":"32","author":"H Laroui","year":"2011","unstructured":"Laroui H, Theiss AL, Yan Y, Dalmasso G, Nguyen HT, Sitaraman SV, Merlin D: Functional TNFalpha gene silencing mediated by polyethyleneimine\/TNFalpha siRNA nanocomplexes in inflamed colon. Biomaterials. 2011, 32: 1218-1228.","journal-title":"Biomaterials"},{"key":"288_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/mt.2008.220","volume":"17","author":"KA Howard","year":"2009","unstructured":"Howard KA, Paludan SR, Behlke MA, Besenbacher F, Deleuran B, Kjems J: Chitosan\/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther. 2009, 17: 162-168.","journal-title":"Mol Ther"},{"key":"288_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.radonc.2010.09.010","volume":"97","author":"I Nawroth","year":"2010","unstructured":"Nawroth I, Alsner J, Behlke MA, Besenbacher F, Overgaard J, Howard KA, Kjems J: Intraperitoneal administration of chitosan\/DsiRNA nanoparticles targeting TNFalpha prevents radiation-induced fibrosis. Radiother Oncol. 2010, 97: 143-148.","journal-title":"Radiother Oncol"},{"key":"288_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2796.2009.02189.x","volume":"267","author":"A Schroeder","year":"2010","unstructured":"Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG: Lipid-based nanotherapeutics for siRNA delivery. J Intern Med. 2010, 267: 9-21.","journal-title":"J Intern Med"},{"key":"288_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1517\/17425247.2010.514604","volume":"7","author":"N Duceppe","year":"2010","unstructured":"Duceppe N, Tabrizian M: Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin Drug Deliv. 2010, 7: 1191-1207.","journal-title":"Expert Opin Drug Deliv"},{"key":"288_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","volume":"14","author":"KA Howard","year":"2006","unstructured":"Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, Hovgaard MB, Schmitz A, Nyengaard JR, Besenbacher F, Kjems J: RNA interference in vitro and in vivo using a novel chitosan\/siRNA nanoparticle system. Mol Ther. 2006, 14: 476-484.","journal-title":"Mol Ther"},{"key":"288_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jconrel.2011.08.023","volume":"157","author":"P Holzerny","year":"2012","unstructured":"Holzerny P, Ajdini B, Heusermann W, Bruno K, Schuleit M, Meinel L, Keller M: Biophysical properties of chitosan\/siRNA polyplexes: profiling the polymer\/siRNA interactions and bioactivity. J Control Release. 2012, 157: 297-304.","journal-title":"J Control Release"},{"key":"288_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.yrtph.2009.09.015","volume":"56","author":"P Baldrick","year":"2010","unstructured":"Baldrick P: The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol. 2010, 56: 290-299.","journal-title":"Regul Toxicol Pharmacol"},{"key":"288_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4161\/cbt.11.9.15465","volume":"11","author":"S Ramakrishnan","year":"2011","unstructured":"Ramakrishnan S: Hydrogel-siRNA for cancer therapy. Cancer Biol Ther. 2011, 11: 849-851.","journal-title":"Cancer Biol Ther"},{"key":"288_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/jbm.a.34354","volume":"101","author":"S Jo","year":"2013","unstructured":"Jo S, Kim S, Cho TH, Shin E, Hwang SJ, Noh I: Effects of recombinant human bone morphogenic protein-2 and human bone marrow-derived stromal cells on in vivo bone regeneration of chitosan-poly(ethylene oxide) hydrogel. J Biomed Mater Res A. 2013, 101: 892-901.","journal-title":"J Biomed Mater Res A"},{"key":"288_CR16","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.4103\/0975-7406.94131","volume":"4","author":"SR Chakavala","year":"2012","unstructured":"Chakavala SR, Patel NG, Pate NV, Thakkar VT, Patel KV, Gandhi TR: Development and in vivo evaluation of silver sulfadiazine loaded hydrogel consisting polyvinyl alcohol and chitosan for severe burns. J Pharm Bioallied Sci. 2012, 4: S54-S56.","journal-title":"J Pharm Bioallied Sci"},{"key":"288_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jbm.a.31676","volume":"86","author":"R Ahmadi","year":"2008","unstructured":"Ahmadi R, de Bruijn JD: Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels. J Biomed Mater Res A. 2008, 86: 824-832.","journal-title":"J Biomed Mater Res A"},{"key":"288_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jbm.a.31365","volume":"83","author":"CD Hoemann","year":"2007","unstructured":"Hoemann CD, Chenite A, Sun J, Hurtig M, Serreqi A, Lu Z, Rossomacha E, Buschmann MD: Cytocompatible gel formation of chitosan-glycerol phosphate solutions supplemented with hydroxyl ethyl cellulose is due to the presence of glyoxal. J Biomed Mater Res A. 2007, 83: 521-529.","journal-title":"J Biomed Mater Res A"},{"key":"288_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0378-5173(00)00428-2","volume":"203","author":"E Ruel-Gariepy","year":"2000","unstructured":"Ruel-Gariepy E, Chenite A, Chaput C, Guirguis S, Leroux J: Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm. 2000, 203: 89-98.","journal-title":"Int J Pharm"},{"key":"288_CR20","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1016\/j.biomaterials.2010.01.139","volume":"31","author":"S Kim","year":"2010","unstructured":"Kim S, Nishimoto SK, Bumgardner JD, Haggard WO, Gaber MW, Yang Y: A chitosan\/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials. 2010, 31: 4157-4166.","journal-title":"Biomaterials"},{"key":"288_CR21","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1016\/j.biomaterials.2010.01.131","volume":"31","author":"L Wang","year":"2010","unstructured":"Wang L, Stegemann JP: Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering. Biomaterials. 2010, 31: 3976-3985.","journal-title":"Biomaterials"},{"key":"288_CR22","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1016\/j.biomaterials.2011.03.065","volume":"32","author":"YH Cheng","year":"2011","unstructured":"Cheng YH, Yang SH, Lin FH: Thermosensitive chitosan-gelatin-glycerol phosphate hydrogel as a controlled release system of ferulic acid for nucleus pulposus regeneration. Biomaterials. 2011, 32: 6953-6961.","journal-title":"Biomaterials"},{"key":"288_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4155\/tde.11.155","volume":"3","author":"S Seth","year":"2012","unstructured":"Seth S, Johns R, Templin MV: Delivery and biodistribution of siRNA for cancer therapy: challenges and future prospects. Ther Deliv. 2012, 3: 245-261.","journal-title":"Ther Deliv"},{"key":"288_CR24","doi-asserted-by":"publisher","first-page":"9642","DOI":"10.1016\/j.biomaterials.2011.08.026","volume":"32","author":"T Manaka","year":"2011","unstructured":"Manaka T, Suzuki A, Takayama K, Imai Y, Nakamura H, Takaoka K: Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials. 2011, 32: 9642-9648.","journal-title":"Biomaterials"},{"key":"288_CR25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3109\/1061186X.2012.725170","volume":"20","author":"T Saito","year":"2012","unstructured":"Saito T, Tabata Y: Preparation of gelatin hydrogels incorporating small interfering RNA for the controlled release. J Drug Target. 2012, 20: 864-872.","journal-title":"J Drug Target"},{"key":"288_CR26","doi-asserted-by":"publisher","first-page":"9204","DOI":"10.1021\/ja9037615","volume":"131","author":"MD Krebs","year":"2009","unstructured":"Krebs MD, Jeon O, Alsberg E: Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. J Am Chem Soc. 2009, 131: 9204-9206.","journal-title":"J Am Chem Soc"},{"key":"288_CR27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.4161\/cbt.11.9.15185","volume":"11","author":"HD Han","year":"2011","unstructured":"Han HD, Mora EM, Roh JW, Nishimura M, Lee SJ, Stone RL, Bar-Eli M, Lopez-Berestein G, Sood AK: Chitosan hydrogel for localized gene silencing. Cancer Biol Ther. 2011, 11: 839-845.","journal-title":"Cancer Biol Ther"},{"key":"288_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jbm.b.30596","volume":"80","author":"H Akncbay","year":"2007","unstructured":"Akncbay H, Senel S, Ay ZY: Application of chitosan gel in the treatment of chronic periodontitis. J Biomed Mater Res B Appl Biomater. 2007, 80: 290-296.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"288_CR29","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/0142-9612(95)98126-Y","volume":"16","author":"KY Lee","year":"1995","unstructured":"Lee KY, Ha WS, Park WH: Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials. 1995, 16: 1211-1216.","journal-title":"Biomaterials"},{"key":"288_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0142-9612(98)00159-8","volume":"20","author":"H Onishi","year":"1999","unstructured":"Onishi H, Machida Y: Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials. 1999, 20: 175-182.","journal-title":"Biomaterials"},{"key":"288_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0142-9612(96)00167-6","volume":"18","author":"K Tomihata","year":"1997","unstructured":"Tomihata K, Ikada Y: In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials. 1997, 18: 567-575.","journal-title":"Biomaterials"},{"key":"288_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1163\/156856208783719482","volume":"19","author":"SM Lim","year":"2008","unstructured":"Lim SM, Song DK, Oh SH, Lee-Yoon DS, Bae EH, Lee JH: In vitro and in vivo degradation behavior of acetylated chitosan porous beads. J Biomater Sci Polym Ed. 2008, 19: 453-466.","journal-title":"J Biomater Sci Polym Ed"},{"key":"288_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7150\/thno.5743","volume":"3","author":"F Iversen","year":"2013","unstructured":"Iversen F, Yang C, Dagnaes-Hansen F, Schaffert DH, Kjems J, Gao S: Optimized siRNA-PEG conjugates for extended blood circulation and reduced urine excretion in mice. Theranostics. 2013, 3: 201-209.","journal-title":"Theranostics"},{"key":"288_CR34","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3109\/0284186X.2012.726373","volume":"52","author":"I Nawroth","year":"2013","unstructured":"Nawroth I, Alsner J, Deleuran BW, Dagnaes-Hansen F, Yang C, Horsman MR, Overgaard J, Howard KA, Kjems J, Gao S: Peritoneal macrophages mediated delivery of chitosan\/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model. Acta Oncol (Stockholm, Sweden). 2013, 52: 1730-1738.","journal-title":"Acta Oncol (Stockholm, Sweden)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-3155-12-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:29:40Z","timestamp":1630582180000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/1477-3155-12-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1186\/1477-3155-12-23","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]},"assertion":[{"value":"18 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}